Vaxess Technologies, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-10.
Vaxess Technologies, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 10, 2025. The filing reports $7.90M sold. Its industry group is Biotechnology. It names Kathryn Kosuda (Executive Officer, Director), Ann DeWitt (Director), Peter Kolchinsky (Director) (SEC Form D, September 10, 2025).
In its own words: “Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1.” (terrestrialbio.com, checked November 1, 2026)
Is this your company?
Sell to companies like Vaxess Technologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vaxess Technologies, Inc.
Free to see. No signup.
More on the people and the money behind Vaxess Technologies, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in September 2025, largest first.
Get an email when Vaxess Technologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vaxess Technologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch Vaxess Technologies, Inc. →Get the full cited report on Vaxess Technologies, Inc.
What the filing shows about Vaxess Technologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Vaxess Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vaxess Technologies, Inc.'s address as 30 Cummings Park Drive, Woburn, MA 01801.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Terrestrial Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Vaxess Technologies, Inc. See pricing
Vaxess Technologies, Inc. is a registered filer with the SEC (CIK 1578117) and has filed since 2022-10-04. 7 filings are on record, the latest on 2026-03-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vaxess Technologies, Inc.'s Form D of 2025-09-10 names Kathryn Kosuda, Ann DeWitt, Peter Kolchinsky and 8 more as its officers, directors or promoters.
Its new offerings report $95.48M sold across 6 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Kathryn Kosuda is named as Executive Officer and Director on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Ann DeWitt is named as Director on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Peter Kolchinsky is named as Director on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Livio Valenti is named as Executive Officer on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Jonathan Kluge is named as Executive Officer on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Lynda Tussey is named as Executive Officer on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Fenel Eloi is named as Director on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Rachel Sha is named as Executive Officer and Director on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
John Spiridigliozzi is named as Executive Officer on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Matthew Dirckx is named as Executive Officer on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
Weiner Tilsner is named as Executive Officer on the Form D that Vaxess Technologies, Inc. filed with the SEC on 10 September 2025, one of 11 people that filing names.
11 people named on the filing — 8 holding an executive role and 3 as directors only.
Named as of the 2025-09-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Vaxess Technologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Vaxess Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vaxess Technologies, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vaxess Technologies, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vaxess Technologies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Vaxess Technologies, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vaxess-technologies-inc-form-d-25000001